Laetitia Michou

Dr. Laetitia Michou


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Joint Bone Spine
Verified
Journal Article
Closed access
LMLaetitia Michou
Laetitia Michou
JLJean-Luc Lermusiaux
Jean-Luc Lermusiaux
JTJean-Pierre Teyssedou
Jean-Pierre Teyssedou
TBThomas Bardin
Thomas Bardin
JBJohann Beaudreuil
Johann Beaudreuil
EPElisabeth Petit-Teixeira
Elisabeth Petit-Teixeira


1 July 2012 in Joint Bone Spine
Verified
Journal Article
Closed access
LMLaetitia Michou
Laetitia Michou
CCCorinne Collet
Corinne Collet
JMJean Morissette
Jean Morissette
MAMaurice Audran
Maurice Audran
TTThierry Thomas
Thierry Thomas
POPhilippe Orcel
Philippe Orcel

1 March 2011 in Bone
Verified
Journal Article
Closed access
LMLaetitia Michou
Laetitia Michou
JMJean Morissette
Jean Morissette
EGEdith R. Gagnon
Edith R. Gagnon
AMAnik Marquis
Anik Marquis
MDMaryann Dellabadia
Maryann Dellabadia
ESEthel S. Siris
Ethel S. Siris

14 August 2014 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
RKRoscoe Klinck
Roscoe Klinck
GLGino Laberge
Gino Laberge
MBMartine Bisson
Martine Bisson
SMStephen McManus
Stephen McManus
LMLaetitia Michou
Laetitia Michou
SRSophie Roux
Sophie Roux
Mutations in the SQSTM1/p62 gene have been reported in Paget’s disease of bone (PDB), but they are not sufficient to induce the pagetic osteoclast (OC) phenotype. We hypothesized that specific RNA isoforms of OC-related genes may contribute to the overactivity of pagetic OCs, along with other genetic predisposing factors.

31 October 2012 in Bone
Verified
Journal Article
Open access
LMLaetitia Michou
Laetitia Michou
NCNatércia Conceição
Natércia Conceição
JMJean Morissette
Jean Morissette
EGEdith Gagnon
Edith Gagnon
GMGabriel Miltenberger-Miltenyi
Gabriel Miltenberger-Miltenyi
LCLeonor Cancela
Leonor Cancela
We performed a genetic association study of rare variants and single nucleotide polymorphisms (SNPs) of UCMA/GRP and OPTN genes, in French-Canadian patients with Paget's disease of bone (PDB) and in healthy controls from the same population. We reproduced the variant found in the UCMA/GRP basal promoter and tested its functionality using in vitro transient transfection assays. Interestingly, this SNP rs17152980 appears to affect the transcription level of UCMA/GRP. In addition, we have identified five rare genetic variants in UCMA/GRP gene, four of them being population-specific, although none were found to be associated with PDB. Six Tag SNPs of UCMA/GRP gene were associated with PDB, particularly the SNP rs17152980 (uncorrected P = 3.8 × 10− 3), although not significant after Bonferroni's correction. More importantly, we replicated the strong and statistically significant genetic association of two SNPs of the OPTN gene, the rs1561570 (uncorrected P = 5.7 × 10− 7) and the rs2095388 (uncorrected P = 4.9 × 10− 3), with PDB. In addition, we identified a very rare variant found to be located close to the basal promoter of the OPTN gene, at − 232 bp from its distal transcription start site. Furthermore, depending on the type of allele present (G or A), the binding of several important nuclear factors such as the vitamin D or the retinoic acid receptors is predicted to be altered at this position, suggesting a significant effect in the regulation of transcription of the OPTN gene. In conclusion, we identified a functional SNP located in the basal promoter of the UCMA/GRP gene which provided a weak genetic association with PDB. In addition, we replicated the strong genetic association of two already known SNPs of the OPTN gene, with PDB in a founder effect population. We also identified a very rare variant in the promoter of OPTN, and through bioinformatic analysis, identified putative transcription factor binding sites likely to affect OPTN gene transcription.